Clinical Trial Update: Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML [Phase 1, Phase 2]

View source ↗

Summary

Dose-escalation study of clofarabine in combination with cytarabine and idarubicin as induction therapy for high-risk acute myeloid leukemia (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)
• Idarubicin (idarubicin)

Snippet

Sponsor: Hannover Medical School | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN